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ABSTRACT: Post Traumatic Stress Disorder (PTSD) is a 
medical condition characterized by symptoms of anxiety and 
depression occurring in people who have a history of traumatic 
events. This disorder was initially diagnosed in patients that have 
been exposed to violent events, such as rape or war. Recently, 
however, PTSD has been also recognized in patients that survived 
after intensive care unit (ICU) stay. This phenomenon seems to 
be related to dysfunction of the hypothalamus-pituitary-adrenal 
axis (HPA) observed in patients treated in ICUs. Since it is known 
that severe sepsis and septic shock may lead to a situation called 
critical illness-related corticosteroid insufficiency (CIRCI), we 
hypothesized that PTSD development after severe sepsis could 
also be related to HPA dysfunction during sepsis treatment. We 
performed a literature search, using different databases and diverse 
combinations of the terms PTSD, sepsis and HPA. Fifteen articles 
were retrieved and only three filled all the requisites. These three 
publications were reviewed here. We conclude that the available 
data are not sufficient to confirm a direct relationship between a 
sepsis-related hypothalamic-pituitary-adrenal axis dysfunction 
and the development of post-traumatic stress disorder. Although 
there is concrete evidence about the existence of this correlation, 
the published articles represent the work of just one research 
group, include few patients and did not take into consideration 
the effect of the intensive care stay in their conclusions.
KEYWORDS: Intensive care unit; Stress disorders, post-
traumatic; Hydrocortisone; Critical illness; Hypothalamus; 
Depression; Anxiety; Sleep disorders.
RESUMO: Transtorno de Estresse Pós-Traumático (TEPT) é 
uma condição médica caracterizada por sintomas de ansiedade e 
depressão que ocorrem em pessoas que têm uma história de eventos 
traumáticos. Esta doença foi inicialmente diagnosticada em pacien-
tes que tenham sido expostos a eventos violentos, como estupro 
ou guerra. Recentemente, no entanto, o TEPT tem sido também 
reconhecido em pacientes que sobreviveram após internação na 
unidade de terapia intensiva (UTI). Esse fenômeno parece estar 
relacionado a uma disfunção do eixo hipotálamo-pituitária-adrenal 
(HPA) observada em pacientes tratados em UTIs. Uma vez que é 
sabido que a sepse grave e o choque séptico podem levar a uma 
situação chamada insuficiência de corticosteroides relacionado a 
doença crítica (CIRCI), formulou-se a hipótese de que o desenvol-
vimento de PTSD após sepse grave também pode estar relacionado 
a uma disfunção do eixo HPA durante o tratamento da sepse. Foi 
realizada uma pesquisa bibliográfica, utilizando-se diferentes bases 
de dados e diversas combinações dos termos PTSD, sepse e HPA. 
Quinze artigos foram recuperados e apenas três preencheram todos 
os requisitos. Estas três publicações foram revistas aqui. Conclui-se 
que os dados disponíveis não são suficientes para confirmar uma 
relação direta entre a disfunção do eixo hipotálamo-hipófise-adrenal 
relacionada à sepse e ao desenvolvimento do transtorno de estresse 
pós-traumático. Embora haja provas concretas sobre a existência 
dessa correlação, os artigos publicados representam o trabalho de 
apenas um grupo de pesquisa, incluem poucos pacientes e não 
levam em consideração o efeito da internação na UTI em suas 
conclusões.
DESCRITORES: Unidades de terapia intensiva; Transtornos 
de estresse pós-traumático; Hidrocortisona; Estado terminal; 
Hipotálamo; Ansiedade; Transtornos do sono.
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INTRODUCTION
Post-traumatic stress disorder
Post-Traumatic Stress Disorder (PTSD) was recognized as a medical entity almost half a century ago, initially in Vietnam 
War veterans that presented symptoms of depression and 
anxiety1. Later, this diagnosis was applied also to survivors 
of rape, assault or other violent traumatic events2. 
Nowadays, DSM-5 established some criteria for the 
diagnosis, divided in clusters3:
History of traumatic event;	
Intrusion: recurrent, involuntary, and intrusive 	
memories; unpleasant nightmares;
Avoidance: persistent effortful avoidance of distressing 	
trauma-related stimuli after the event;
Negative alterations in cognition and mood: persistent 	
distorted blame of self or others for causing the 
traumatic event or for resulting consequences and 
persistent negative trauma-related emotions;
Alterations in arousal and reactivity: irritable or 	
aggressive behavior, self-destructive or reckless 
behavior,  problems in concentration, sleep 
disturbance;
Persistence of symptoms for more than one month.	
In more recent years, some authors noticed that 
patients that survived after being treated for severe illnesses 
in Intensive Care Units (ICUs) presented later with 
symptoms that resemble the ones described by patients 
diagnosed with PTSD4,5. 
PTSD etiology is still not completely understood, 
and several factors seem to affect the outcome of the 
disease, including genetic variations6 (Wang et al. 2011) and 
trauma intensity7. Among the main mechanisms described 
to explain the development of PTSD, the dysfunction of 
the hypothalamic-pituitary-adrenocortical (HPA) axis 
seems to be one of the most important8. Nevertheless, this 
relationship between PTSD and HPA has been described 
mainly in post violent traumatic events and no consensus 
exists regarding the role of this mechanism in PTSD after 
ICU treatment. 
Intensive care and sepsis
Sepsis is the most common diagnosis in ICUs around 
the world9, including Brazil10. Severe sepsis and septic 
shock develop when the initial appropriate response of the 
host to a bacterial or fungal infection becomes amplified, 
and then deregulated11. Clinically, the onset is insidious, 
with fever, mental confusion, urinary and hematological 
changes. The patient may then develop respiratory and 
/ or renal failure, coagulation disorders and hypotension 
unresponsive to treatment12. The mortality in these cases, 
worldwide, is about 30-50%13,14, similar to the data in the 
Intensive Care Unit of our service.
Sepsis pathophysiology is the result of complex 
interactions between the host immune system and 
the invading pathogens. One interesting point in this 
phenomenon is the role played by the HPA axis. There 
is a relative adrenal insufficiency in critically ill patients 
is approximately 20%, with an incidence as high as 60% 
in patients with severe sepsis and septic shock15. The 
mechanisms leading to inadequate cortisol production 
during critical illness are complex, poorly understood, and 
likely include decreased production of CRH, ACTH, and 
cortisol16, as described below.
From the studies described above, it seems clear 
that PTSD and critical illness, particularly severe sepssis 
and septic shock, share a common pathophysiologic 
mechanism, that is, a marked dysfunction of the HPA axis. 
Therefore, in order to better understand this relationship, it 
is necessary to detail the HPA axis, in health and disease.
The hypothalamus-pitutitary-adrecortical axis
Cortisol (hydrocortisone) is the major endogenous 
glucocorticoid secreted by the adrenal cortex. Cholesterol 
is the principal precursor for steroid biosynthesis; at rest 
and during stress, approximately 80% of circulating cortisol 
is derived from plasma cholesterol, with the remaining 
20% being synthesized in situ from acetate and other 
precursors17. The adrenal gland does not store cortisol; 
increased secretion arises due to increased synthesis under 
the control of adrenocorticotrophic hormone (ACTH) by 
the anterior pituitary gland which, by itself, is stimulated 
by corticotropin-releasing hormone (CRH), released by 
paraventricular nucleus of the hypothalamus16. This part 
of the hypothalamus is sensitive to adrenal needs and is 
the responsible for triggering the whole process of cortisol 
secretion. 
Once secreted, over 90% of circulating cortisol is 
bound to corticosteroid-binding globulin (CBG) with 10% 
in the free, biologically active form18. The circulating half-
life of cortisol varies from 70 to 120 min, with a biological 
half-life of approximately 6 to 8 h.
Further, in order to exert its effects, cortisol binds 
to specific receptors on the cell nuclei, the glucocrticoid 
receptors, or GRs19. Two isoforms of the GR have been 
isolated, namely GR-α and GR-β. The GR-β isoform fails 
to bind cortisol and activate gene expression, and thus, 
functions as a negative inhibitor of GR-α19, adding another 
complexity level to the process. 
During the past decade, it was recognized that many 
critically ill patients present a corticosteroid deficiency, 
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even though their cortisol secretion was in the normal 
range. The term Critical Illness-Related Corticosteroid 
Insufficiency (CIRCI) was then coined to describe this 
clinical entity16 (Marik 2009). 
PTSD, sepsis and the HPA axis
Considering that:
it is well known that during sepsis a marked dysfunction 	
of the HPA axis is observed;
patients treated in ICUs present higher incidence of 	
posttraumatic stress disorder;
it has been described that there is a direct correlation 	
of the development of PTSD and dysfunction of HPA 
axis;
our main objective in this study is to determine whether 	
there is a higher incidence of PTSD in patients that 
survived from severe sepsis or septic shock and the 
role of exogenous corticosteroid administration in this 
phenomenon.
METHODOLOGY
The literature search was conducted using 
computerized databases including PUBMED, SciELO and 
LILACS, regardless the time the articles were published. 
Our main search strategy consisted of the following 
keywords: “posttraumatic stress disorder” AND “sepsis” 
AND “cortisol”. The term “post-traumatic stress disorder” 
was also substituted by “PTSD”; the term “sepsis” was 
also sought as “septic shock”; the term “cortisol” was also 
researched as “corticosteroids”, “hypothalamic-pituitary-
adrenocortical axis” or “HPA axis”. Abstracts were read 
thoroughly before complete articles were obtained and the 
references from the relevant publications were manually 
explored to ascertain further potential articles. The search 
was restricted to studies that were published in English 
or in Portuguese. Observational studies and retrospective 
analysis were not eliminated. Case reports/case series and 
review were not considered.
RESULTS
Based on the initial search results, 15 titles and 
abstract were examined. One additional publication was 
retrieved by hand search of the references. Twelve articles 
were excluded, since they did not present any data related 
to the main focus of our work. Most of these articles refer 
to PTSD and critical care units, with no particular interest 
in sepsis. One study was not considered because it was 
a review written by the same authors of other studies. In 
the end, only three studies were reviewed that contain 
the relationship between sepsis, the HPA axis and further 
development of PTSD.
The first article to explore this relationship was 
written in 1999, by Schelling et al.20. In this study, authors 
used a retrospective case-controlled analysis of 27 patients 
who received standard septic-shock treatment and compared 
them to another septic shock group, with the same number 
of patients that received supplemental hydrocortisone in 
doses equivalent to the maximal endocrine secretion rate. 
Medical records after ICU discharge were scanned in order 
to find the prevalence of PTSD. PTSD was diagnosed using 
the Posttraumatic Stress Syndrome-10 question inventory 
and quality of life measured with the Medical Outcomes 
Study Short Form Survey. The result of the study was that 
hydrocortisone treatment during septic shock significantly 
lowered the incidence of PSTD (as only 5 of the 27 patients 
of the group developed PTSD in contrast to the protocol-
driven control group in which 16 of the 27 did) and could 
improve the quality of life, long after the ICU discharge, 
in patients who were treated for severe sepsis or septic 
shock.
Further, in 2001, the same group published another 
study using a different approach21. This time authors 
recruited patients (n=20) from an on going prospective, 
randomized double-blind study on the hemodynamic effects 
of hydrocortisone during septic shock. Eleven patients had 
received placebo and nine stress doses of hydrocortisone. 
Posttraumatic stress disorder was diagnosed 31 months 
(median) after intensive care unit discharge using specific 
tests based on the DSM-IV criteria. Furthermore, the 
number of categories of traumatic memory from ICU 
treatment was determined in both groups at that time. 
Confirming the results presented in their previous study, 
only one of nine patients from the hydrocortisone group 
developed posttraumatic stress disorder, compared with 
seven of 11 patients in the placebo group (p=0.02). 
There was no significant difference with regard to the 
number of categories of traumatic memory between the 
hydrocortisone and placebo groups. Their conclusion was 
that the administration of hydrocortisone during septic 
shock in a dosage similar to the endogenous maximal 
production rate was associated with a lower incidence of 
posttraumatic stress disorder in long-term survivors, which 
seems to be independent of the number of categories of 
traumatic memory.
Finally, in 2006, another study was published, 
where the same authors present a new series of cases, 
with, actually, no new findings22. It was a review, with 
a few new data, confirming their previous findings and 
introducing to their discussion the new concept of critical 
illness-related corticosteroid insufficiency (CIRCI). 
Although no new information was provided in this study, 
their discussion is more extensive. They list studies which 
point to a relationship between the HPA axis, glucocorticoid 
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signaling, ICU patients and development of PTSD. The 
results indicate that the administration of hydrocortisone 
to CIRCI patients can bring about many benefits. These 
include the treatment of CIRCI and its implications, such as 
the extinction of traumatic memory retrieval from patients. 
It is necessary to observe here, that their review focused on 
patients at an ICU, and not in patients with the particular 
diagnostic of sepsis.
As a conclusion for their three articles, the authors 
state that regulation of the glucocorticoid signalling is 
essential for controlling stress or, at least, that administration 
of exogenous hydrocortisone be involved. They also state 
that this presents a whole new treatment procedure for 
ICU patients, who also represent an interesting group 
for observing the effects of stress hormones and the 
development of PTSD.
DISCUSSION
There was a limited number of articles focused 
on the role of critical illness-related corticosteroid 
insufficiency (CIRCI) or the hypthalamic-pituitary-adrenal 
(HPA) axis on the development of Post-Traumatic Stress 
Disorder (PTSD) in patients with severe sepsis or septic 
shock20-23. Interestingly these articles were limited to only 
one group, from the Ludwig-Maximilians-University, 
Munich, Germany.
The main difficulty comes from the fact that all 
patients diagnosed with severe sepsis or septic shock are 
currently treated in ICUs24. As described previously4,5, 
it is well known that patients treated in ICUs have a 
higher chance of developing PTSD. Moreover, this late 
sequelae may be avoided if patients receive supplemental 
corticosteroids during their ICU stay8.
Therefore, in order to know with certainty whether 
sepsis by itself (and its related CIRCI) are the cause of 
PTSD, this confounding factor (the ICU stay) should be 
eliminated. Unfortunately, this is not possible at the present 
moment, what renders our main question impossible to 
answer based solely on the current literature
Nevertheless, we can envision series of experiments 
that could help clarify this issue in the future. 
First, we believe that a large number of patients 
would be necessary to address this subject. The studies 
reported here were unicentric and enroled a small number of 
patients20-23. We can think of a large sample of ICU patients 
divided in four groups: Septics receiveng CE, Non-Septics 
receiving CE, Septics not receiving CE and Non-septics not 
receiving CE. These patients would be paired for time of 
ICU, previous diseases, age, and other factors. A thorough 
statistical analysis could be performed and, if the number of 
patients is large enough, an answer whether sepsis related 
CIRCI is the responsible for late PTSD development. 
Other approaches involve the development 
of laboratory and genetic markers of PTSD and their 
application to the follow-up of septic patients. Although 
some attempts have been made in this field25 no marker is 
already in sue in the clinical set. This kind of approach, 
however, may be a promising pathway in the near future.
CONCLUSION
The available data are not sufficient to confirm a 
direct relationship between a sepsis-related hypothalamic-
pituitary-adrenal axis dysfunction and the development 
of prost-traumatic stress disorder. Although there is 
concrete evidence about the existence of this correlation, 
the published articles represent the work of just one 
research group, include few patients and did not take into 
consideration the effect of the intensive care stay in their 
conclusions. 
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